Financial Results Approval

  • Approved Unaudited Financial Results for Q2 and half year ended September 30, 2026
  • Limited Review Report of Auditors conducted by SR BC & CO LLP (Firm registration number: 324982E/E300003) attached
  • Financial results show Q2 FY27 Net Sales of ₹1,692 crore (₹1,507 crore in Q2 FY26), representing 12.2% YoY growth
  • Half-year sales reached ₹3,282 crore (₹2,928 crore in H1 FY26), representing 12.1% growth
  • Q2 Net Profit after tax stood at ₹342 crore (₹328 crore in Q2 FY26)
  • Basic and Diluted EPS for Q2 FY27: ₹12.56 (₹12.04 in Q2 FY26)
  • Half-year EPS: ₹25.17 (₹23.83 in H1 FY26)

Dividend Declaration

  • Declared First Interim Dividend of ₹24 per equity share (face value Re. 1) for FY 2026-27
  • Total dividend payout: ₹6,527.7 lakhs
  • Record date: November 2, 2026
  • Payment date: On and from November 19, 2026

Management Appointments

  • Appointed Ms. Ragini Gajaria as Internal Auditor effective October 22, 2026
  • Ms. Gajaria is a qualified Chartered Accountant with expertise in risk-based internal auditing and enterprise risk management
  • Previously served as Senior Manager – Risk Management and Internal Audit at Asian Paints Limited

Management Changes

  • Mr. Gunjit Jain resigned as Executive Vice President Marketing effective November 30, 2026 to pursue professional growth opportunity outside company
  • Mr. Akash Parekh appointed as Executive Vice President - Marketing effective December 1, 2026
  • Mr. Parekh has nearly 17 years with Colgate-Palmolive across India, North America and APAC regions
  • Currently serves as Senior Director, Marketing - APAC

Corporate Governance

  • Seeking shareholder approval for Mr. Manish Anandani's (DIN: 07257875) appointment as Managing Director & CEO via postal ballot
  • Cut-off date for postal ballot: October 23, 2026
  • M/s. S. N. Ananthasubramanian & Co., Practicing Company Secretaries appointed as Scrutinizers
  • Mr. S. N. Ananthasubramanian (FCS 4206) or Mr. S. N. Viswanathan (FCS 13685) to conduct the process

Financial Highlights (Q2 FY27 vs Q2 FY26)

  • Total Income: ₹1,727.5 lakhs vs ₹1,534.5 lakhs
  • Revenue from Operations: ₹1,705.7 lakhs (Sales: ₹1,691.6 lakhs + Other Operating Income: ₹14.2 lakhs)
  • Other Income: ₹21.7 lakhs
  • Total Expenses: ₹1,267.3 lakhs
  • Profit Before Tax: ₹460.2 lakhs
  • Tax Expense: ₹122.7 lakhs (Current Tax) + (₹4.1 lakhs) Deferred Tax
  • Net Profit: ₹341.6 lakhs

Balance Sheet Position (as of September 30, 2026)

  • Total Assets: ₹3,637.7 lakhs
  • Current Assets: ₹2,477.8 lakhs (including Cash & Cash Equivalents: ₹15,877.4 lakhs)
  • Total Equity: ₹1,617.6 lakhs
  • Paid-up Equity Share Capital: ₹272.0 lakhs
  • Other Equity: ₹1,590.4 lakhs

Cash Flow (Six months ended September 30, 2026)

  • Net cash from operating activities: ₹8,387.9 lakhs
  • Net cash from investing activities: (₹169.5 lakhs)
  • Net cash used in financing activities: (₹6,601.4 lakhs)
  • Net increase in cash: ₹1,617.0 lakhs

Notes to Financial Results

  • Exceptional item for six months ended September 30, 2026: ₹334 lakhs (severance and related expenses)
  • Company has only one reportable segment: 'Personal Care (including Oral Care)'
  • No subsidiary/associate/joint venture entities
  • Results reviewed by Audit Committee and approved by Board on October 22, 2026